Blog

Part D coverage determination and exception: the step order that works

A Part D plan will not cover a drug, tiers it high or requires step therapy: the steps from coverage determination to appeal, with a sample prescriber note.

A Part D plan that says no to a drug at the pharmacy has not said no to the prescription. The "no" at the counter is a claim rejection. The plan's formal decision comes only when someone asks for it, and the formal request, called a coverage determination, is what opens the door to exceptions and appeals. Most of the delay people experience comes from skipping that step, or from sending the request without the one document the plan needs most: a statement from the prescriber.

This playbook puts the steps in the order that tends to work. Every number of days below is a general rule for Medicare drug plans; the plan's own notices state the dates that apply to you.

Step 1: Find out exactly why the plan said no

A drug can be stopped at the counter for five different reasons, and each calls for a different request:

  • Not on the formulary. The plan does not list the drug at all (see formulary).
  • On the formulary, but at a high tier. The drug is covered but your copay or coinsurance is more than you can afford (see formulary tier).
  • Prior authorization required. The plan wants approval before it will pay (see prior authorization).
  • Step therapy required. The plan wants you to try one or more cheaper drugs first (see step therapy).
  • A quantity limit. The plan covers a set number of pills or doses per month and your prescription exceeds it (see quantity limit).

Ask the pharmacist for the rejection message and write it down. When a Part D claim is rejected, the pharmacy is supposed to hand you a notice explaining how to ask the plan for a coverage determination. If you did not receive one, ask for it. The blog post Medicare would not cover my drug at the pharmacy: what do I do next? covers what to do in the first minutes at the counter.

Step 2: Look at what the plan actually says

Before making a request, spend ten minutes with the plan's materials:

  1. The formulary. Is the drug listed? On what tier? With what restrictions (PA, ST, QL)? Plans publish these online and update them during the year.
  2. The list of alternatives. If the drug is excluded, which covered drugs treat the same condition? Your prescriber needs to know these, because an exception depends on explaining why they are not appropriate for you.
  3. The plan's coverage determination form and phone number. Most plans post a request form on their website. You can also ask by phone, online or in writing.

This is also the moment to ask the plan whether a transition supply applies, which is the subject of Step 6.

Step 3: Ask the prescriber for a supporting statement

This step matters most. For an exception, Medicare requires a statement from the prescriber, and the plan's clock for deciding generally starts when it has that statement. A request filed without it can sit.

What the prescriber must say depends on what you are asking for:

  • A formulary exception (a drug not on the list): that every covered drug for your condition would not work as well for you or would cause harm.
  • A tiering exception (a lower cost for a drug on a high tier): that the preferred alternatives would not work as well or would harm you.
  • A utilization management exception (waiving prior authorization, step therapy or a quantity limit): that the requirement would be less effective or harmful for you, or that you have already tried and failed the required step.

Call the prescriber's office, not just the pharmacy. Tell the person at the desk: "My Part D plan rejected this prescription. I need a prescriber's supporting statement for a coverage determination. Can you send it to the plan today?" Ask which form they will use (many plans accept a letter) and how they will fax or upload it. Ask for a copy for your records.

A sample structure for the statement

The prescriber writes it, but the family can hand a clinic this outline. It is a structure only; the content comes from the chart.

  1. Identifiers: patient name, date of birth, plan member ID, drug name, strength, dose and quantity.
  2. Diagnosis: the condition the drug treats.
  3. History: the drugs tried before, each with dates, doses and outcome (did not work, side effects, allergic reaction, contraindicated).
  4. Why formulary alternatives will not do: specific clinical reasons, such as an interaction with another medicine, a prior failure, a condition that makes the alternative unsafe or a stable response to the requested drug.
  5. What happens if the plan's preferred approach is required: the clinical risk of switching, such as relapse or loss of control.
  6. The request: which exception, and a statement that the request should be expedited if waiting could seriously harm health.
  7. Signature and contact information: the prescriber's name, number and date.

Everything in the statement should be traceable to the chart. A plan reviewer reads dozens of these. Dates, doses and outcomes persuade; adjectives do not.

Step 4: File the coverage determination, standard or fast

Submit the request to the plan by whichever route is fastest: the plan's online portal, fax, phone, or the form. The prescriber can file it for you.

  • Standard request: the plan has up to 72 hours to decide. For an exception, the 72 hours generally run from the day the plan receives the supporting statement.
  • Expedited request: the plan has 24 hours. The standard is that your prescriber says a standard 72-hour wait could seriously jeopardize your life, your health or your ability to regain maximum function. If your prescriber supports the request in that way, the plan must expedite.

Be accurate about urgency. A fast review is for cases of genuine clinical risk (running out of a seizure medication, for example). It is not for convenience, and the prescriber is the one who attests.

When the plan decides, it sends a written notice. If it approves, the notice states how long the approval lasts. An approved exception generally stays in force for the rest of the plan year as long as the prescription is valid and the drug remains safe for you, and it should be tracked at renewal. If it denies, the notice gives a reason and tells you how to appeal.

Step 5: If the answer is no, appeal in the order Medicare sets out

A refusal is not the end. The ladder for Part D drug denials looks like this:

  1. Redetermination by the plan. You, your representative or your prescriber ask the plan to look again. The deadline is on the denial notice, on the order of two months. A different reviewer decides, and a physician reviews medical necessity questions. The plan has 7 days to decide a standard request and 72 hours for an expedited one.
  2. Independent review. If the plan upholds the denial, you can ask an independent review entity to decide. Unlike Medicare Advantage medical appeals, this level is not automatic for Part D: you or your prescriber must request it, within the time on the redetermination notice. The reviewer has 7 days (standard) or 72 hours (expedited).
  3. Administrative law judge, Medicare Appeals Council and federal court. These later levels depend on dollar thresholds that Medicare updates each year. The Medicare Advantage version of the ladder is described in Medicare Advantage appeal levels from reconsideration to federal court; the later steps are similar.

At the redetermination stage, add anything the plan said was missing and respond directly to its reason. If the plan wrote "alternatives are clinically appropriate," your prescriber's second letter should say, point by point, why they are not.

A worked clock, with invented dates

These numbers are an illustration using the standard time limits. Say a prescriber's statement reaches the plan on Day 0.

Stage Standard Expedited
Coverage determination up to 72 hours (3 days) 24 hours (1 day)
Redetermination up to 7 days 72 hours (3 days)
Independent review up to 7 days 72 hours (3 days)
Total if all three levels are used 17 days (3 + 7 + 7) 7 days (1 + 3 + 3)

Add the time to file between steps, because the reviewer's clock starts only when each request arrives. Someone who waits weeks to appeal loses that time, not the plan. This is why the prescriber's statement and a prompt filing at each step shorten the process more than anything else.

Step 6: Ask about a transition fill while you wait

Medicare drug plans must have a transition process for people new to the plan and for some continuing members affected by formulary changes. In general, it provides a temporary supply of a drug that would otherwise be rejected, often a one-month supply, during the first stretch of coverage under the plan, commonly the first 90 days. It exists to give you time to switch to a covered drug or to get an exception approved.

Ask the plan, in writing if possible:

  • Does my situation qualify for a transition supply?
  • How many days or doses does it cover, and does it apply at my pharmacy?
  • Will the plan send a notice that explains how to request an exception? (It generally must.)

This does not replace the coverage determination. Ask for the transition fill and file the exception request in the same week, because the transition supply runs out.

Step 7: Plan for next year if the answer stays no

As of November 2026, the Annual Enrollment Period for Medicare, October 15 through December 7, is under way. A drug that a plan refuses to cover for 2026 may be covered by a different plan for 2027, or by the same plan on a different tier. The approach:

For reference, the standard Part D benefit in 2026 has a $615 deductible and a $2,100 out-of-pocket threshold, and in 2027 those amounts are $700 and $2,400, per CMS's CY 2027 rate announcement. Spending on a drug the plan covers under an exception counts toward that threshold as it does for any covered drug, so a covered drug at a high tier still brings you closer to the cap. See The Part D out-of-pocket cap and the Medicare Prescription Payment Plan for how the cap and the monthly payment option work.

A SHIP counselor (see the glossary entry on SHIP) will compare plans for your drug list free of charge, and can help file an exception if you are stuck.

If the problem is step therapy

A step therapy requirement is the most common reason for a utilization management exception, and the evidence needed is specific: which cheaper drugs you tried, for how long, what happened. The guide step therapy explained: "fail first" rules and how to get an exception and the checklist post step therapy exceptions: the reasons that win and how to document each cover the usual grounds and the chart evidence for each.

Mistakes that slow people down

  • Waiting for the pharmacy to fix it. A rejected claim does not start the plan's clock; a coverage determination does.
  • Filing without the prescriber's statement. For exceptions the clock may not start until the plan has it.
  • Asking for an expedited review when the situation is not urgent. The plan can ask the prescriber to confirm, and a false claim erodes credibility.
  • Forgetting that Part D independent review is not automatic. If the plan upholds its denial, you have to ask for the next level.
  • Not tracking the exception's end date. Ask when the approval expires so a refill is not rejected the next January.

Key takeaways

  • A rejection at the pharmacy is not the plan's decision; the coverage determination request is what starts the formal process.
  • A prescriber's supporting statement, with drug history and specific clinical reasons, is the most important document for any Part D exception.
  • Standard coverage determinations take up to 72 hours and expedited ones 24 hours; redeterminations take up to 7 days (72 hours expedited), and independent review must be requested.
  • Ask about a transition supply at the same time you file, and plan for next year using Annual Enrollment Period, which runs through December 7.
  • A SHIP counselor and the plan's own appeals notices can confirm your dates and help with the forms.

Terms used in this guide

Related tools

Related guides

Latest on this topic